Dr Reddy shares hit a series of record highs on all-round strong Q1 performance; what should investors do?
Dr Reddy's Laboratories (DRL) shares have scaled a series of record peaks in the past few days. This week, the pharmaceutical major reported a strong all-round quarterly performance, with a better-than-expected 18.2 per cent year-on-year increase in net profit to Rs 1,405 crore for the April-June period.
DRL reported a strong set of financial results for the June quarter on July 26. | Image: Drreddys.com